Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pLenti 4.1 Ex miR200c-141 Citations (7)

Originally described in: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ Nat Cell Biol. 2008 May;10(5):593-601. Epub 2008 Mar 30.
PubMed Journal

Articles Citing pLenti 4.1 Ex miR200c-141

Articles
Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73. Lu Z, Jiao D, Qiao J, Yang S, Yan M, Cui S, Liu Z. Mol Cancer. 2015 May 14;14:102. doi: 10.1186/s12943-015-0370-9. PubMed
Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Kruppel-like factor 8 in breast cancer. Li T, Lu H, Mukherjee D, Lahiri SK, Shen C, Yu L, Zhao J. Oncotarget. 2015 Aug 28;6(25):21428-42. PubMed
Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes. Bhatt S, Gupta MK, Khamaisi M, Martinez R, Gritsenko MA, Wagner BK, Guye P, Busskamp V, Shirakawa J, Wu G, Liew CW, Clauss TR, Valdez I, El Ouaamari A, Dirice E, Takatani T, Keenan HA, Smith RD, Church G, Weiss R, Wagers AJ, Qian WJ, King GL, Kulkarni RN. Cell Metab. 2015 Aug 4;22(2):239-52. doi: 10.1016/j.cmet.2015.07.015. PubMed
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Sciacovelli M, Goncalves E, Johnson TI, Zecchini VR, da Costa AS, Gaude E, Drubbel AV, Theobald SJ, Abbo SR, Tran MG, Rajeeve V, Cardaci S, Foster S, Yun H, Cutillas P, Warren A, Gnanapragasam V, Gottlieb E, Franze K, Huntly B, Maher ER, Maxwell PH, Saez-Rodriguez J, Frezza C. Nature. 2016 Aug 31;537(7621):544-547. doi: 10.1038/nature19353. PubMed
Re-expression of miR-200s in claudin-low mammary tumor cells alters cell shape and reduces proliferation and invasion potentially through modulating other miRNAs and SUZ12 regulated genes. Simpson K, Conquer-van Heumen G, Watson KL, Roth M, Martin CJ, Moorehead RA. Cancer Cell Int. 2021 Feb 4;21(1):89. doi: 10.1186/s12935-021-01784-4. PubMed
miR-200c-141 Enhances Sheep Kidney Cell Reprogramming into Pluripotent Cells by Targeting ZEB1. Zhang Y, He Y, Wu P, Hu S, Zhang Y, Chen C. Int J Stem Cells. 2021 Nov 30;14(4):423-433. doi: 10.15283/ijsc21080. PubMed
Elevated Expression of miR-200c/141 in MDA-MB-231 Cells Suppresses MXRA8 Levels and Impairs Breast Cancer Growth and Metastasis In Vivo. Simpson KE, Watson KL, Moorehead RA. Genes (Basel). 2022 Apr 14;13(4). pii: genes13040691. doi: 10.3390/genes13040691. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.